Icosagen (company)
| Company type | Privately held company |
|---|---|
| Industry | Biotechnology, Biopharmaceutical industry |
| Founded | 1999 |
| Headquarters | Tartu, Estonia |
Key people | Mart Ustav (Founder and CEO) |
| Products | Products and services in functional genomics and proteomics, latex allergen tests |
| Services | Certification: ISO 9001:2000 |
| Website | icosagen |
Icosagen is a biotechnology company in Estonia providing medical diagnostics services and performing custom research programs for the biopharmaceutical industry. As of March 2009, Quattromed has been renamed Icosagen AS.
Profile
Quattromed was established in 1999 as a spin-off from Tartu University. It is based in Tartu, Estonia. Employing 80 full-time employees, it has grown into the largest biotechnology company in Estonia.[citation needed] Quattromed started with offering molecular diagnostic services, and today the company covers molecular and clinical diagnostic (Quattromed HTI Laboratories), life science products (Quattromed), latex allergen testing (Quattromed Ltd) and protein production (Quattromed Cell Factory).[citation needed]
Products and services
Icosagen’s activities are divided into three branches: medical diagnostics division, technology development division, and life science products division. Its main focus is in gene expression and protein production. In-house proprietary technologies are used combined with extensive process know-how and partnership with academic and industrial groups. Quattromed has three patent applications in its IP portfolio, about ten technology licenses and one trademark.
Icosagen’s main products are:
- FITkit (latex allergen test) and FITkit testing service [1]
- E2Tag epitope tagging technology[1][2]
- MAbs to HIV/SIV proteins, epitope tags
- anti-IgG antibodies
- QMCF Technology - a propriety protein production technology (further information)
See also
References
- ^ Kurg R; Parik J; Juronen E; Sedman T; Abroi A; Liiv I; Langel U; Ustav M. (1999). "Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication". Journal of Virology. 73 (6): 4670–7. PMC 112508. PMID 10233926.
- ^ Kaldalu N; Lepik D; Kristjuhan A; Ustav M. (2000). "Monitoring and purification of proteins using bovine papillomavirus E2 epitope tags". BioTechniques. 28 (3): 456–60. PMID 10723557.
External links
- Quattromed Ltd. website
- Icosagen's (formerly Quattromed) FITkit and latex allergen testing
- Icosagen's (formerly Quattromed) life science product catalogue